Uranium

Uranium occurs naturally in rock and can dissolve into groundwater. Drinking contaminated water or breathing uranium-containing workplace dust can increase your exposure without obvious symptoms. At sufficiently high exposure, its chemical toxicity can damage the kidneys. The health effects of long-term, low-level exposure are less certain.

This test measures uranium in whole blood. It can contribute to an investigation of recent exposure, but its interpretation in preventive care remains exploratory. Urine is the better-established specimen for assessing absorbed uranium exposure. A blood concentration alone cannot establish poisoning, identify the source, or predict whether you will develop kidney disease.

Where Uranium Comes From

For most people, food and drinking water are the main sources. Groundwater concentrations depend on local rock and water chemistry, so neighboring water supplies can differ. Private wells can contain substantial uranium even without nearby mining.

Mining, milling, fuel processing, and contaminated mine waste can create additional exposure through dust, soil, and water. Exposure at work depends on the material, the task, and the controls in place. Some military injuries have also left depleted uranium fragments in the body, creating a continuing internal source.

US studies have linked estimated uranium concentrations in community water supplies to uranium measured in urine, including at concentrations below drinking-water limits. A separate investigation of contaminated private wells also linked water concentrations with urinary uranium. These findings establish drinking water as an exposure route; they do not establish a corresponding blood concentration or a blood-based disease threshold.

What a Blood Level Captures

Only a small fraction of swallowed uranium enters the bloodstream. Absorption depends partly on its chemical form and how readily it dissolves. Most swallowed uranium passes out in stool. Absorbed uranium is carried through the blood, with some reaching the kidneys and bone.

Much of the uranium entering circulation is cleared into urine quickly. Some retained material leaves more slowly, particularly from bone or poorly soluble particles in the lungs. Blood therefore gives a limited view of recent circulating uranium and cannot measure the amount stored throughout your body.

Urine is also affected by exposure timing, but it has a stronger evidence base for exposure assessment. Its window is not fixed at two weeks. After prolonged exposure, slow release from bone can keep urinary uranium raised for months to years, and retained depleted uranium fragments can sustain urinary excretion for decades.

The blood measurement uses ICP-MS. This laboratory technique detects very small amounts of an element by separating charged atoms according to mass. The reported concentration does not measure radiation dose or distinguish natural uranium from depleted uranium; identifying that distinction requires a separate analysis of uranium isotopes.

Kidney Tubule Effects

The proximal tubules are small kidney tubes that reclaim glucose, minerals, and small proteins from filtered fluid. They are a main target of uranium's chemical toxicity. Tubule injury can change what appears in urine before it causes a measurable fall in the kidneys' filtration rate.

Human studies of drinking-water exposure have found some changes in urinary glucose, small proteins, and markers of tubule injury. The findings are mixed, and their long-term clinical meaning remains uncertain. The studies below assessed uranium in urine or drinking water, not in blood.

The US tubule study measured exposure and kidney markers at the same time, so it cannot show that uranium caused the changes or that they will progress to kidney disease. The California study followed health outcomes over time, but water-system measurements cannot capture exactly what each person drank. Together, these findings support concern about kidney effects without validating blood uranium as an early kidney-disease screening test.

Blood Pressure and Heart Disease

In the Strong Heart Family Study, higher urinary uranium was associated with developing hypertension among 1,453 American Indian adolescents and adults. This was an observational association based on urine measurements. It does not show that uranium caused hypertension or that a blood result can predict your blood pressure.

Occupational studies address a different exposure pattern. A study of 6,403 Fernald processing workers associated estimated radiation dose to the heart with cardiovascular mortality. An early analysis of the large German Wismut uranium-miner cohort found no clear association between radiation exposure and cardiovascular death. A 2025 update of the same cohort, covering nearly 59,000 men followed through 2018, found a small but statistically significant excess risk of death from ischemic heart disease with increasing radon exposure. These studies involved reconstructed radiation doses and multiple workplace exposures, so they cannot be translated into cardiovascular risk from a blood uranium concentration.

Cancer Risk

The strongest cancer evidence from uranium mining concerns inhaled radon decay products and lung cancer. Radon forms as uranium and its decay products break down in rock. Pooled miner studies show increasing lung cancer risk with cumulative radon exposure. Smoking amplifies that risk: in miners who smoked, the combined effect was larger than the two risks simply added together. Blood uranium does not measure radon exposure.

Evidence about uranium itself is less settled. A study of gaseous diffusion plant workers found an association between reconstructed internal uranium dose and deaths from multiple myeloma. Multiple myeloma is a cancer of antibody-producing cells in bone marrow. Associations with kidney cancer and chronic kidney disease in that analysis were positive but not statistically conclusive.

The Fernald study linked lung cancer mortality to external radiation dose. It did not find a statistically significant association with internal uranium dose. That distinction matters when considering what a uranium blood measurement might mean.

A systematic review found no increase in kidney cancer mortality across the included uranium-exposed populations and found lower mortality from some other kidney diseases. Many included studies compared workers with the general population. People healthy enough to enter and remain in employment can have lower death rates to begin with, which can obscure occupational harm. The review also found that available kidney-function studies were too limited to establish a clear pooled effect.

Long-term surveillance of a small group of veterans with retained depleted uranium fragments found persistently raised urinary uranium without consistent uranium-related injury in the organs assessed. The small study cannot establish safety for every exposure, but it illustrates why detecting uranium and diagnosing harm require different evidence.

When Results Can Be Misleading

• Timing: uranium can leave circulation rapidly. A low blood result after an earlier exposure may miss that exposure, while a sample taken during an unusual exposure may not represent your usual intake.
• Chemical form and retained material: poorly soluble inhaled particles, bone stores, or embedded fragments can release uranium over time. A blood measurement cannot distinguish these sources from new intake.
• Kidney function: kidney function affects uranium handling. A concentration cannot be converted directly into the amount you swallowed or inhaled.
• Sample contamination: dust on skin, contaminated collection equipment, or unsuitable tubes can affect measurements at these very low concentrations.
• Analytical limits: a result below the laboratory's detection limit does not mean no uranium is present. Small differences close to the reporting limit may reflect measurement variation.
• Different specimens and methods: whole blood, serum, plasma, and urine results represent different samples and are not interchangeable. Differences in sample preparation, calibration, and detection limits can also affect comparisons between laboratories.
• Background exposure: detectable uranium can occur without harmful exposure. A personal baseline is useful context, but it is not evidence that a concentration is safe.

Tracking Your Trend

Repeated blood measurements can show whether the circulating concentration has changed under comparable collection conditions. A decline may be consistent with reduced recent exposure, but it does not prove that stored uranium has cleared or that kidney health has improved. Exposure history, environmental measurements, urinary uranium, and kidney findings provide the context needed to interpret a trend.